LENZ Therapeutics
IPOPublic · Burlingame, United States · Founded 2013 · $160.5M raised
- Headquarters
- Burlingame, California
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2C
- Website
- lenz-tx.com
- Total Funding
- $160.5M
- Last Round
- $30.0M Private EquityJul 2024
- Rounds
- 3
- Type
- Public
About
LENZ Therapeutics is a pharmaceutical company commercializing VIZZ (aceclidine ophthalmologic solution) 1.44%, the first FDA-approved aceclidine eye drop for presbyopia. HQ San Diego.
Summary
LENZ Therapeutics is a Biotech company based in Burlingame, United States, founded in 2013. It has raised $160.5M in total across 3 rounds, most recently a $30.0M Private Equity round in Jul 2024. Investors include Ridgeback Capital, Sectoral Asset Management and Jerel Davis.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...